A new echocardiographic index to select patients for PFO suture-mediated percutaneous closure
- PMID: 36841947
- DOI: 10.1002/ccd.30604
A new echocardiographic index to select patients for PFO suture-mediated percutaneous closure
Abstract
Objectives: To identify a simple echocardiographic predictor of procedural success to select patient for percutaneous suture-mediated patent fossa ovalis (PFO) closure.
Background: Percutaneous suture-mediated PFO closure has been shown as a safe and advantageous alternative to device-based PFO closure, yet its overall success is slightly lower in unselected patients.
Methods: Preprocedural transesophageal echocardiogram (TEE) of 302 patients (113 men, 45 ± 12 years) who underwent percutaneous suture-mediated PFO closure were reviewed.
Results: At echocardiographic follow-up (3-6 months), residual right-to-left shunt (RLS) ≥2 was found in 60 (19.9%) patients. At multivariable analysis, only two anatomical variables measured at preprocedural TEE were found as independent predictors of residual RLS ≥ 2 at follow-up: PFO maximum width (odds ratio [OR] 1.89, 95% confidence interval [CI] 1.16-3.40, p = 0.02) and PFO minimal septa overlapping (OR 0.58, 95% CI 0.35-0.88, p = 0.02). An index based on the ratio of PFO maximum width to PFO minimum septal overlapping (W/SO) proved to be the most powerful predictor of RLS ≥ 2 at follow-up (OR 48.1, 95% CI 9.3-352.2, p < 0.01). The ROC curve for the W/SO ratio was found to have an AUC of 0.84 (95% CI 0.75-0.93) and a cut-off value of 0.61 yielding a sensitivity of 80% and specificity of 78% with a negative predictive value of 94%. A decision tree methodology's AUC was 0.75 (95% CI 0.67-0.83).
Conclusions: The results of this study indicate that the ratio between the maximum amplitude of the PFO and the minimum overlap of the septa is the best predictive index of a favorable result by using one stitch only.
Keywords: anatomy; echocardiography; patent fossa ovalis; percutaneous closure; suture.
© 2023 Wiley Periodicals LLC.
Comment in
-
Refining the NobleStitch PFO closure technique using an anatomy-tailored approach.Catheter Cardiovasc Interv. 2023 Jun;101(7):1245-1246. doi: 10.1002/ccd.30661. Epub 2023 May 2. Catheter Cardiovasc Interv. 2023. PMID: 37130438 No abstract available.
References
REFERENCES
-
- Mas JL, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377:1011-1021.
-
- Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377:1022-1032.
-
- Søndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377:1033-1042.
-
- Gaspardone A, De Marco F, Sgueglia GA, et al. Novel percutaneous suture-mediated patent foramen ovale closure technique: early results of the NobleStitch EL Italian Registry. EuroIntervention. 2018;14:e272-e279.
-
- Gaspardone A, Sgueglia GA. Suture-mediated patent fossa ovalis closure: The NobleStitch technique. In: Sabatè M, Brugaletta S, eds. Percutaneous Cardiac Interventions Textbook. Tips and Tricks of New Techniques Beyond Stenting. 2nd ed. Europa Digital and Publishing; 2019.
MeSH terms
LinkOut - more resources
Full Text Sources